Ropinirol Sandoz Retard 2 mg

Ropinirol Sandoz Retard 2 mg is a medicine authorised by Swissmedic under authorisation number 62480. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 December 2012 and the authorisation is valid without a time limit. ATC code N04BC04 places the medicine in the group Anti-Parkinson drugs.

  • Dispensing category B
  • Authorisation number 62480
  • ATC N04BC04
  • Synthetic medicines
Authorisation data
Authorisation number62480
NameRopinirol Sandoz Retard 2 mg
Full nameRopinirol Sandoz Retard 2 mg, Tablette mit veränderter Wirkstofffreisetzung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN04BC04
First authorisation04 December 2012
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ropinirol Sandoz Retard 2 mg, Tablette mit veränderter WirkstofffreisetzungB04 December 2012
2Ropinirol Sandoz Retard 4 mg, Tablette mit veränderter WirkstofffreisetzungB04 December 2012
3Ropinirol Sandoz Retard 8 mg, Tablette mit veränderter WirkstofffreisetzungB04 December 2012

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
228Tablette(n)N04BC0401.08.0.B
328Tablette(n)N04BC0401.08.0.B
428Tablette(n)N04BC0401.08.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ropinirol Sandoz Retard 2 mg authorised in Switzerland?

Yes. Ropinirol Sandoz Retard 2 mg is authorised by Swissmedic under authorisation number 62480, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ropinirol Sandoz Retard 2 mg have?

Ropinirol Sandoz Retard 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ropinirol Sandoz Retard 2 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com